The identification of promising and shared therapeutic targets, such as DPP-4, GLP-1R, and TrκB, in different diseases, such as AD, PD, and HD, suggest its importance in therapeutic approaches to NDs. This evidence concerns the gene DPP4 and Parkinson disease.